[Omaron in the rehabilitation of post stroke outpatients].
The study aimed at the evaluation of clinical efficacy and safety of the neurotrophic medication omaron, a combination of piracetam and cinnarizin, in the early restoration period of ischemic stroke. One hundred and twenty post stroke patients were examined. A diagnosis was confirmed by the brain MRI and CT examination. Neurological and mental status of patients was assessed with a number of scales. The omaron therapy reduced significantly the neurological deficit and improved health status and functioning of patients. The drug was well-tolerated by patients.
Chuprina
S E
SE
D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002936:Cinnarizine / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D020521:Stroke / Q000503:physiopathology / Q000523:psychology; D000071939:Stroke Rehabilitation
D002121:Calcium Channel Blockers; D004338:Drug Combinations; D018696:Neuroprotective Agents; D002936:Cinnarizine; D010889:Piracetam